These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 428186)

  • 1. Influence of pentobarbital on effect and plasma levels of alprenolol and 4-hydroxy-alprenolol.
    Collste P; Seideman P; Borg KO; Haglund K; von Bahr C
    Clin Pharmacol Ther; 1979 Apr; 25(4):423-7. PubMed ID: 428186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.
    Ablad B; Borg KO; Johnsson G; Regårdh CG; Sölvell L
    Life Sci; 1974 Feb; 14(4):693-704. PubMed ID: 4823626
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.
    Collste P; Borg KO; Aström H; von Bahr C
    Clin Pharmacol Ther; 1979 Apr; 25(4):416-22. PubMed ID: 34497
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.
    Seideman P; Borg KO; Haglund K; Von Bahr C
    Br J Clin Pharmacol; 1987 Mar; 23(3):267-71. PubMed ID: 3567041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pentobarbital on the disposition of alprenolol.
    Alván G; Piafsky K; Lind M; von Bahr C
    Clin Pharmacol Ther; 1977 Sep; 22(3):316-21. PubMed ID: 891097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pentobarbital on metoprolol plasma levels.
    Haglund K; Seideman P; Collste P; Borg KO; von Bahr C
    Clin Pharmacol Ther; 1979 Sep; 26(3):326-9. PubMed ID: 466926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of biological interaction of alprenolol and salicylate in man.
    Johnsson G; Regårdh CG; Sölvell L
    Eur J Clin Pharmacol; 1973 Jun; 6(1):9-14. PubMed ID: 4764375
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.
    Collste P; Haglund K; Frisk-Holmberg M; Rawlins MD
    Eur J Clin Pharmacol; 1976 Jun; 10(2):85-8. PubMed ID: 9292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Dec; 14(5):305-8. PubMed ID: 729623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfeldt A
    Clin Pharmacol Ther; 1977 Jun; 21(6):675-84. PubMed ID: 324693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.
    Collste P; Haglund K; Frisk-Holmberg M; Orme ML; Rawlins MD; Ostman J
    Eur J Clin Pharmacol; 1976 Jun; 10(2):89-95. PubMed ID: 964292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 13. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic changes in muscle on long-term alprenolol therapy.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfelt A; Karlsson J
    Clin Pharmacol Ther; 1979 Nov; 26(5):566-71. PubMed ID: 498698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term anti-hypertensive beta-receptor-blocking treatment on haemodynamic and metabolic responses to prolonged exercise in man.
    Frisk-Holmberg M; Juhlin-Dannfeldt A; Jorfeldt L; Aström H
    Clin Sci Mol Med Suppl; 1976 Dec; 3():489s-491s. PubMed ID: 1071668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism (s) of alprenolol (beta adrenergic receptor blocking agent) prolongation of pentobarbital hypnosis in mice.
    Peters MA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):417-24. PubMed ID: 4402372
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prolonged beta-blockade on energy metabolism and adrenergic responses in the rat.
    Harri MN
    Med Biol; 1977 Oct; 55(5):268-76. PubMed ID: 592903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of dl-propranolol and l-and d-alprenolol on arterial pressure in awake or anesthesized, normo- or hypertensive rats].
    Davy M; Cohen Y; Wepierre J
    C R Seances Soc Biol Fil; 1975; 169(2):306-12. PubMed ID: 126761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.